These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8067786)

  • 1. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S; Rikken B; Hokken-Koelega A; Wit JM; Drop S
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators.
    Rekers-Mombarg LT; Massa GG; Wit JM; Matranga AM; Buckler JM; Butenandt O; Chaussain JL; Frisch H; Leiberman E; Yturriaga R; Aarskog D; Chatelain PG; Colle M; Dacou-Voutetakis C; Delemarre-van de Waal HA; Girard F; Gosen JJ; Irle U; Jansen M; Jean R; Job JC; Kaar ML; Kollemann F; Lenko HL; Waelkens JJ
    J Pediatr; 1998 Mar; 132(3 Pt 1):455-60. PubMed ID: 9544901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of nitrogen and whole-body protein metabolism in growth hormone-deficient children by recombinant human growth hormone: relationship to growth.
    Zeisel HJ; Willgerodt H; Richter I; Keller E; Mix M; Vilser C; Amendt P; Hinkel GK; Stach B; Jung K
    Horm Res; 1992; 37 Suppl 2():14-21. PubMed ID: 1490663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E; Haffner D; Tönshoff B; Mehls O
    Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone replacement therapy and bone metabolism in children.
    Zamboni G; Antoniazzi F; Tatò L
    J Pediatr Endocrinol; 1993; 6(1):33-7. PubMed ID: 8374686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts.
    Tönshoff B; Haffner D; Mehls O; Dietz M; Ruder H; Blum WF; Heinrich U; Stöver B
    Kidney Int; 1993 Jul; 44(1):199-207. PubMed ID: 7689125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D; Wühl E; Schaefer F; Nissel R; Tönshoff B; Mehls O
    J Am Soc Nephrol; 1998 Oct; 9(10):1899-907. PubMed ID: 9773791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.
    Boersma B; Rikken B; Wit JM
    Arch Dis Child; 1995 May; 72(5):427-31. PubMed ID: 7618910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age].
    Qie D; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):247-53. PubMed ID: 26975824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.